Palm Beach, FL – (November 29, 2018) – The demand for CBD-based products is steadily rising as the cannabis market continues to gain momentum via sweeping legalization in North America, as well as natural economic growth as it settles into the mainstream consumer markets. Consumer interest in CBD products has dramatically spiked over the past year, with searches on Google nearly doubling in frequency from last year at this time. The Hemp Business Journal estimates CBD-based products will generate nearly $2 billion in annual revenues by 2022. Leaders in the CBD market are privy of this current opportunity and consumer interest and are in turn developing a wide range of CBD-infused products, ranging from everyday food and beverage items to products with more poignant health benefits. Active companies in the markets today include: The Alkaline Water Company Inc. (TSX-V:WTER) (OTC:WTER), New Age Beverages Corporation (NASDAQ:NBEV), MedMen Enterprises Inc. (CSE:MMEN) (OTC:MMNFF), Heineken N.V. (OTC:HEINY), Youngevity International Inc. (NASDAQ:YGYI).
The Alkaline Water Company Inc. (TSX-V:WTER.V) (OTCQB:WTER) BREAKING NEWS: The Alkaline Water Company announced today that its wholly-owned subsidiary, A88 Infused Beverage Division, Inc. (A88 Infused), has entered into a Binding Letter of Agreement (the “Agreement”) with Infusion Biosciences, Inc. (IBS), that provides a non-exclusive license to utilize its proprietary Aqueous Phytorecovery Process (APP) technology. Under the Agreement, IBS will provide A88 Infused with ready-to-drink natural hemp-extract formulations. With APP’s formulations A88 Infused will be the first national U.S. beverage company to bring true water-soluble, full-spectrum features of bioactive natural hemp extract molecules to U.S. consumers.
“With the benefit of IBS’s CEO Dr. Arup Sen’s knowledge and formulations, we are positioned to take a leadership position in the emerging natural hemp extract infused beverage category. Coming off the heels of another consecutive record revenue quarter, generated from our rapidly growing national retail footprint, we believe the launch of our new natural hemp extract infused products will provide a significant increase to our sales growth and provide for another record year,” stated Richard A. Wright, President and CEO of The Alkaline Water Company Inc.
“The quality and purity of IBS’s formulations are uniquely aligned with our commitment to ‘clean beverages’ that our nearly 50,000 retailers and loyal Alkaline88® consumers have come to trust and expect from us. These proprietary formulations will allow us to infuse water-soluble hemp extract without the use of any chemicals or additives. Being truly water soluble, they will absorb through the stomach and the small intestines, therefore allowing for rapid absorption within minutes. Combining this science and technology with the power and integrity of the Alkaline88® brand creates a market-leading approach to the fast-growing hemp beverage category,” concluded Mr. Wright
IBS is a biotech company focused on discovering and commercializing innovative products that use cannabis and hemp plant ingredients in their natural forms produced by the APP Technology. APP Technology comprises a patent-pending process that uses proprietary reagents to produce two unique, ready-to-consume ingredients with the full-spectrum features of bioactive cannabinoids and terpenes from hemp. These are Infuz2O, which is a solution of naturally water-soluble molecules, including cannabinoids and terpenes, directly from the plants; and Bio-Natural Oil, which are free, naturally-occurring oils, including cannabinoids and terpenes, recovered as a natural oil from the plants. Due to the retention of the natural state, both Infuz2O and Bio-Natural Oil are unique in that both deliver plant specific experience in novel products. APP Technology is based on more than 12 years of research and development of water-soluble minerals and plant phytochemicals. Read this and more news for Alkaline Water Company at: https://financialnewsmedia.com/news-wter/
In other industry developments in the markets:
New Age Beverages Corporation (NASDAQ: NBEV) recently announced the closing of its previously announced underwritten public offering of 12,900,000 shares of New Age’s common stock, at a price of $3.50 per share, plus an additional 1,935,000 shares of its common stock pursuant to the full exercise of the over-allotment option granted to the underwriters. The Company estimates net proceeds from the offering to be approximately $49 million, after deducting underwriting discounts and estimated offering expenses. This year, New Age debuted its portfolio of CBD-infused relaxation tea’s, CBD-infused sparkling waters, and CBD-infused shots, each with 25mg of full-spectrum CBD. Planned launch with major retailers and distributors nationally as soon as the Farm Bill is enacted, utilizing New Age’s existing national distribution footprint and penetration in 40 of the top 50 retailers in North America. CBD portfolio, other New Age brands, and store brand/private label offerings expected to round out New Age’s portfolio and position the company as the authority in the emerging and high-growth healthy beverage category.
MedMen Enterprises Inc. (CSE:MMEN.CN) (OTCQX:MMNFF) recently announced it has signed a definitive agreement (the “Agreement”) to acquire the retail operations and license for a location in Santa Ana, California, through an all-stock transaction with Captor Capital Corp. (CPTR.CN). The store is currently MedMen branded and managed. Upon closing, MedMen will issue 3,740,228 Class B subordinate voting shares (the “Shares”) to Captor Capital Corp., a Canadian publicly-traded investment company. At the current market price of the Shares, the transaction is valued at approximately US$16,000,000. The final purchase price is subject to adjustment for accrued liabilities at the time of closing. “MedMen Orange County is strategically located in one of the most affluent regions of Southern California with a limited number of licensed dispensaries,” said Adam Bierman, MedMen chief executive and co-founder. “This is an asset that we are already intimately familiar with through the management contract. We have direct visibility to market data, including consumer demographics and growth trends. This acquisition enhances our first mover advantage in a strategic location with robust sales and long-term growth potential.”
Heineken N.V. (OTCQX:HEINY) in the news: Lagunitas, Heineken’s fast-growing California beer label, bills its new brew as “hoppy sparkling water.” That’s because these cans of brew contain zero alcohol. Instead of booze, the beer-like beverage is made with THC, the main psychoactive ingredient in marijuana. Called Hi-Fi Hops, Lagunitas’ new cannabis drink is the latest wave of a larger move by established companies diving into the marijuana industry. In addition to a brew made with THC, the ingredient in marijuana that causes a high, Lagunitas’ new “beer” is also available with CBD, the non-psychoactive cannabis component that’s thought to be responsible for many of its therapeutic effects. Having only launched on July 30, the brew is currently available in a handful of marijuana dispensaries in California, where the drug is legal. So we visited Oakland’s Harborside dispensary, located on the East Bay peninsula between the neighborhoods of Fruitvale and Downtown Oakland, to check out the new $8 drink. Read the full article here: https://www.businessinsider.com/heineken-marijuana-beer-taste-photos-lagunitas-2018-8
Youngevity International Inc. (NASDAQ:YGYI) recently announced that Carpe Canum Media released “The Audacity of Health: The Dr. Joel Wallach Story,” a documentary on the Youngevity founder. It follows Dr. Wallach’s life and career from his early work in the 1960’s studying one of the first mass (animal) die-offs from pollution and helping to save the White Rhino in Africa, to his work in the 70’s discovering the correlation between nutritional deficiencies in animals and disease, and how it extends into humans. It also looks at Dr. Wallach’s successful petition to get the FDA to include specific nutrients like folate and selenium as required dietary nutrients and for all supplement manufacturers to allow disease risk claims on nutritional supplements. Youngevity also has only recently entered the CBD market, but the company has grand plans. “We firmly believe in plant-based nutrition, and hemp (CBD) oil perfectly complements our product development philosophy,” said Steve Wallach, the company’s CEO. “Entering this market, which is growing almost exponentially, also should offer a tremendous advantage to our many distributors around the world.”
DISCLAIMER: FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty six hundred dollars for news coverage of the current press release issued by The Alkaline Water Company Inc. by a non-affiliated third party consultant. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.
Media Contact email: email@example.com – +1(561)325-8757